The effect of dietary fiber on gut barrier function, gut microbiota, short-chain fatty acids, inflammation and clinical outcomes in critically ill patients: a systematic review and meta-analysis
Liu, Ting, Wang, Can, Wang, YuYu, Wang, Li-li, Ojo, Omorogieva ORCID: https://orcid.org/0000-0003-0071-3652, Feng, Qian-Qian, Jiang, Xiao-Song and Wang, Xiaohua (2021) The effect of dietary fiber on gut barrier function, gut microbiota, short-chain fatty acids, inflammation and clinical outcomes in critically ill patients: a systematic review and meta-analysis. Journal of Parenteral and Enteral Nutrition, 46 (5). pp. 997-1010. ISSN 0148-6071 (Print), 1941-2444 (Online) (doi:10.1002/jpen.2319)
Preview |
PDF (Author's accepted manuscript (AAM))
34826_OJO_The_effect_of_dietary_fiber.pdf - Accepted Version Download (1MB) | Preview |
Abstract
Background: Although some studies have explored the relationships between dietary fiber (DF) supplement and gut barrier function, changes of gut microbiota and other clinical outcomes in critically ill patients, the results from different studies were not consistent. Objective: The purpose of this study was to explore the effect of dietary fiber on gut barrier function, gut microbiota, short-chain fatty acids (SCFAs), inflammation and clinical outcomes in critically ill patients. Methods: A search was performed through PubMed, Embase, the Cochrane Central Register of Clinical Trials, Web of Science and EBSCO-host that includes Health Sciences Research from inception to July 12, 2021. Data were pooled using fixed effects model for low heterogeneity and random effects model for high heterogeneity. Data were expressed as mean difference (MD) or odds ratio (OR) with confidence interval. Results: A total of 21 studies involving 2084 critically ill patients were included. The results showed that there was a significant reduction in intestinal permeability demonstrated by lactulose/rhamnose ratio (MD:-0.04; 95%CI:-0.08, -0.00; P=0.03) on day 8 in DF supplement group. Three studies reported the relative abundance (RA) of gut microbiota and the results showed the RA of some SCFAs producers increased higher in DF supplement group. There was a significant decrease in C-reactive protein on day 14 (MD:-36.66; 95%CI:-44.40, - 28.93; P<0.001) and the duration of hospital stay (MD:-3.16; 95%CI:-5.82, -0.49; P<0.05) after DF supplement. There were no significant differences on SCFAs levels, the duration of mechanical ventilation and mortality between the two groups. However, in subgroup analysis, the results indicated there was a significant reduction on the duration of mechanical ventilation in fiber combined probiotic group (MD:-13; 95%CI:-19.69, -6.31; P<0.05).
Item Type: | Article |
---|---|
Uncontrolled Keywords: | dietary fiber: gut barrier function; gut microbiota; inflammation; clinical outcomes; critically ill patients |
Subjects: | R Medicine > RA Public aspects of medicine > RA0421 Public health. Hygiene. Preventive Medicine R Medicine > RT Nursing |
Faculty / School / Research Centre / Research Group: | Faculty of Education, Health & Human Sciences Faculty of Education, Health & Human Sciences > Institute for Lifecourse Development Faculty of Education, Health & Human Sciences > Institute for Lifecourse Development > Centre for Chronic Illness and Ageing Faculty of Education, Health & Human Sciences > School of Health Sciences (HEA) |
Related URLs: | |
Last Modified: | 24 Dec 2022 01:38 |
URI: | http://gala.gre.ac.uk/id/eprint/34826 |
Actions (login required)
View Item |
Downloads
Downloads per month over past year